ScoreWhy is NovoCure Ltd. ?
1
Positive results in Sep 25
- OPERATING CASH FLOW(Y) Highest at USD -34.48 MM
- NET PROFIT(HY) Higher at USD -77.41 MM
- CASH AND EQV(HY) Highest at USD 1,950.05 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -42.57%, its profits have fallen by -25.3%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Below par performance in long term as well as near term
- Along with generating -42.57% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to NovoCure Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is NovoCure Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
NovoCure Ltd.
-41.3%
-0.68
69.03%
S&P 500
13.68%
0.71
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.39%
EBIT Growth (5y)
-256.94%
EBIT to Interest (avg)
-88.42
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.76
Sales to Capital Employed (avg)
0.57
Tax Ratio
26.48%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
12.06%
ROE (avg)
0.63%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.13
EV to EBIT
-6.42
EV to EBITDA
-6.95
EV to Capital Employed
18.62
EV to Sales
1.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-290.16%
ROE (Latest)
-51.77%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -34.48 MM
NET PROFIT(HY)
Higher at USD -77.41 MM
CASH AND EQV(HY)
Highest at USD 1,950.05 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 4.02 times
NET SALES(Q)
Highest at USD 167.2 MM
-3What is not working for the Company
ROCE(HY)
Lowest at -50.6%
RAW MATERIAL COST(Y)
Grown by 5.17% (YoY
Here's what is working for NovoCure Ltd.
Operating Cash Flow
Highest at USD -34.48 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -77.41 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
Highest at USD 167.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Cash and Eqv
Highest at USD 1,950.05 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 4.02 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
Highest at USD 3.66 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for NovoCure Ltd.
Raw Material Cost
Grown by 5.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
